News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cappella Medical Devices Limited to Share Long Term Clinical Benefits of its Sideguard® Technology at EuroPCR 2012



5/15/2012 10:20:45 AM

PARIS--(BUSINESS WIRE)--Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, is pleased to announce new long term follow up clinical data for its innovative Sideguard® coronary sidebranch system. This new data, to be announced this week, continues to validate the importance of protecting the ostium with the unique scaffolding design of the Sideguard® stent resulting in long term preservation of the coronary sidebranch.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES